• Study Resource
  • Explore
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Efficacy, safety and tolerability of an orally administered
Efficacy, safety and tolerability of an orally administered

... Objective: Cannabis may alleviate some symptoms associated with multiple sclerosis (MS). This study investigated the effect of an orally administered standardized Cannabis sativa plant extract in MS patients with poorly controlled spasticity. Methods: During their inpatient rehabilitation programme, ...
INDIVIDUAL VERSUS TECHNOLOGY Research, treatment and policy
INDIVIDUAL VERSUS TECHNOLOGY Research, treatment and policy

5 May 2015 Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome
5 May 2015 Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome

... underlies the production of the symptoms. We cannot explain the symptoms on a physiological, immunological, structural or biochemical basis. Despite all the current research we have no specific target for drug development. We therefore have no drug that can influence the natural history or prognosis ...
Mental Health Clinical Activities - Trinity Valley Community College
Mental Health Clinical Activities - Trinity Valley Community College

... 2. Attend or observe an adjunctive therapy and/or a treatment team meeting; describe and discuss their purpose in post conference. 3. Watch and discuss the electroconvulsive therapy video and possibly observe an electroconvulsive treatment (ECT). Prior to attending, review your psychiatric textbook ...
Benlysta(belimumab)
Benlysta(belimumab)

... • See “What is the most important information I should know about BENLYSTA?” • 1. Cancer. BENLYSTA may reduce the activity of your immune system. Medicines that affect the immune system may increase your risk of certain cancers. • 2. Allergic (hypersensitivity) and infusion reactions. Serious aller ...
BTUH hospital only
BTUH hospital only

...  drug treatment is complex and requires frequent monitoring and dose adjustment  a GP would not be expected to have the specialist knowledge to be able to accept clinical responsibility for prescribing a drug However, for other drugs a shared care arrangement may be suitable where a hospital clini ...
File
File

... All FDA approved medications must provide clinical study results to support approval FDA does not develop or test products; FDA experts review the results of laboratory, animal, and human clinical testing done by manufacturers If FDA grants an approval, it means the agency has determined that the be ...
Ocular immunopathology
Ocular immunopathology

... ‹Inflammation leads to an influx of large numbers of cells ‹Patterns of cytokine secretion change during the course of disease ‹The tissue does not return to its basal state ...
Rheumatoid Arthritis
Rheumatoid Arthritis

... she lacked clinical evidence of other diagnoses, and in fact, had a very high titer rheumatoid factor as well as classic findings of erosive RA on hand x-rays. This case illustrates the importance of viewing RA as a systemic disease, not simply a problem of joints ...
ENDOCTRINOLOGY REFERRAL
ENDOCTRINOLOGY REFERRAL

... Diagnosis / Symptomatology Adverse Drug Reactions ...
The Ataxias: Research in FRDA, SCA, MSA
The Ataxias: Research in FRDA, SCA, MSA

... Is a larger study worth doing, will there be problems? ...
Forty Seven Inc. Completes $75M Series A Financing and Licenses
Forty Seven Inc. Completes $75M Series A Financing and Licenses

... About Forty Seven Inc. Forty Seven Inc. is a clinical-stage immuno-oncology company that is developing therapies licensed from Stanford University targeting cancer immune evasion pathways. The lead program Hu5F9-G4 is a monoclonal antibody against the CD47 receptor, a “don’t eat me” signal that canc ...
Lung Volume Reduction Brochure - New York Presbyterian Hospital
Lung Volume Reduction Brochure - New York Presbyterian Hospital

... expected to be the third leading cause of death in the world. because of medical advancements, the outlook for patients with copd has improved dramatically. there are a variety of treatment options for these patients, including new medications, oxygen and pulmonary rehabilitation. most patients with ...
InterStim ® Therapy for Urinary Control
InterStim ® Therapy for Urinary Control

... and the symptoms of overactive bladder, including urinary urge incontinence and significant symptoms of urgency-frequency alone or in combination, in patients who have failed or could not tolerate more conservative treatments. Contraindications: Diathermy. Patients who have not demonstrated an appro ...


... expected to be the third leading cause of death in the world. because of medical advancements, the outlook for patients with copd has improved dramatically. there are a variety of treatment options for these patients, including new medications, oxygen and pulmonary rehabilitation. most patients with ...
Respiratory disease in cattle
Respiratory disease in cattle

... Fig 3: Selection based upon inspection can by very misleading and miss early clinical disease. ...
BSc in Medical Sciences with GASTROENTEROLOGY AND
BSc in Medical Sciences with GASTROENTEROLOGY AND

... Aims  To appreciate how genetic and environmental factors contribute to GI and liver diseases.  To learn about the scientific principles linking metabolic, genetic and nutritional factors to GI function and disorders. Content  Specific gene/environment interactions in GI diseases such as IBD and ...
Aksje-Norge - Biotec Pharmacon ASA
Aksje-Norge - Biotec Pharmacon ASA

... Secondary: Proportion of patients with target ulcers than heal within 12 weeks Time to healing of target ulcers Percent change in target ulcer area Recurrence of healed targets ulcers within 12 weeks after healing ...
Diapositiva 1
Diapositiva 1

... are tremendous access problems with medicines long ago off patent. Even if antiretroviral HIV/AIDS drugs were made available free tomorrow, there is a lack of health care infrastructure to conduct testing, store and distribute medications, and monitor patient compliance with what are often very com ...
Symptomatic Treatment of MS 28. Which MS symptoms can be
Symptomatic Treatment of MS 28. Which MS symptoms can be

... MS and can lead to a variety of symptoms such as fatigue, loss of appetite, or lack of interest. Conversely, many of these symptoms lead to the diagnosis of depression. Addressing depression and treatment of depression can improve the patient’s quality of life. Psychologists or psychiatrists familia ...
Anti-food polysaccharide antibody formation in Inflammatory
Anti-food polysaccharide antibody formation in Inflammatory

... high level of antibodies against yeast polysaccharide such as ß-glucans. These antibodies may be a factor triggering gut inflammation through over-activation of the gut immune system in IBD patients. In this project, we hypothesise IBD patients develop antibodies against other food polysaccharides ( ...
the leeds teaching hospitals nhs trust
the leeds teaching hospitals nhs trust

...  Assist the registered nurse in the care of deceased patients  Assist in the safe disposal of linen and clinical waste from the clinical area ...
Clinically Amyopathic Dermatomyositis MDA
Clinically Amyopathic Dermatomyositis MDA

... CT Chest with contrast at the level of the carina and basilar lung 10/2015 10/6/15 CT PE: Motion artifact renders evaluation of the distal pulmonary arteries suboptimal. Within these confines there no pulmonary emboli in the main, lobar, or proximal segmental pulmonary arteries. Diffuse groundglass ...
1554_Herbst_PL54F3
1554_Herbst_PL54F3

Faculty of Infectious and Tropical Diseases
Faculty of Infectious and Tropical Diseases

... and social scientists, clinical scientists, public health engineers and geographers. This range of expertise provides us with a battery of tools for focusing on the control of diseases that are insect-borne, water-borne or associated with poor hygiene – mostly in developing countries. Much of the re ...
< 1 ... 465 466 467 468 469 470 471 472 473 ... 554 >

Multiple sclerosis research

Treatments under investigation for multiple sclerosis may improve function, curtail attacks, or limit the progression of the underlying disease. Many treatments already in clinical trials involve drugs that are used in other diseases or medications that have not been designed specifically for multiple sclerosis. There are also trials involving the combination of drugs that are already in use for multiple sclerosis. Finally, there are also many basic investigations that try to understand better the disease and in the future may help to find new treatments.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report